1887
Volume 2013, Issue 2
  • ISSN: 2305-7823
  • EISSN:
Preview this article:

Loading

Article metrics loading...

/content/journals/10.5339/gcsp.2013.16
2013-08-01
2024-03-29
Loading full text...

Full text loading...

/deliver/fulltext/gcsp/2013/2/gcsp.2013.16.html?itemId=/content/journals/10.5339/gcsp.2013.16&mimeType=html&fmt=ahah

References

  1. Chan KMJ, Punjabi PP, Flather MD, Wage R, Symmonds K, Roussin I, Rahman-Haley S, Pennell DJ, Kilner PJ, Dreyfus GD, Pepper JR, for the RIME Investigators . Coronary artery bypass surgery with or without mitral valve annuloplasty in moderate functional ischemic mitral regurgitation: final results of the Randomized Ischemic Mitral Evaluation (RIME) trial. Circulation. 2012; 126:21:25022510
    [Google Scholar]
  2. Bonow RO, Carabello BA, Kanu C, de Leon AC Jr, Faxon DP, Freed MD, Gaasch WH, Lytle BW, Nishimura RA, O'Gara PT, O'Rourke RA, Otto CM, Shah PM, Shanewise JS, Smith SC Jr, Jacobs AK, Adams CD, Anderson JL, Antman EM, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Lytle BW, Nishimura R, Page RL, Riegel B. 2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the ACC/AHA task force on practice guidelines. Circulation. 2008; 118::e523e661
    [Google Scholar]
  3. “The Moderate Mitral Regurgitation in Patients Undergoing CABG trial”. www.clinicaltrials.gov identification number: NCT00613548
  4. Myers J, Gullestad L, Vagelos R, Do D, Bellin D, Ross H, Fowler MB. Cardiopulmonary exercise testing and prognosis in severe heart failure: 14/ml/kg/min revisited. Am Heart J. 2000; 139::7884
    [Google Scholar]
  5. Arena R, Myers J, Williams MA, Gulati M, Kligfield P, Balady GJ, Collins E, Fletcher G. Assessment of functional capacity in clinical and research settings. A scientific statement from the AHA Committee on Exercise, Rehabilitation and Prevention of the Council on Clinical Cardiology and the Council on Cardiovascular Nursing. Circulation. 2007; 116::329343
    [Google Scholar]
  6. Baughman KL. B-type natriuretic peptide – a window to the heart. N Engl J Med. 2002; 347:3:158159
    [Google Scholar]
  7. Zoghbi WA, Enriquez-Sarano M, Foster E, Grayburn PA, Kraft CD, Levine RA, Nihoyannopoulos P, Otto CM, Quinones MA, Rakowski H, Stewart WJ, Waggoner A, Weissman NJ, American Society of Echocardiography . Recommendations for the evaluation of the severity of native valvular regurgitation with two dimensional and Doppler echocardiography. J Am Soc Echocardiogr. 2003; 16:7:777802
    [Google Scholar]
  8. Lancellotti P, Moura L, Pierard LA, Agricola E, Popescu BA, Triboulloy C, Hagendorff A, Monin JL, Badano L, Zamorano JL, European Association of Echocardiography . European Association of Echocardiography recommendations for the assessment of valvular regurgitation. Part 2: mitral and tricuspid regurgitation (native valve disease). Eur J Echocardiogr. 2010; 11:4:307332
    [Google Scholar]
  9. Gelsomino S, Lorusso R, De Cicco G, Capecchi I, Rostagno C, Caciolli S, Romagnoli S, Broi UG, Stefano P, Gensini GF. Five-year echocardiographic results of combined undersized mitral ring annuloplasty and coronary artery bypass grafting for chronic ischaemic mitral regurgitation. Eur Heart J. 2008; 29:2:231240
    [Google Scholar]
  10. Bondarenko O, Beek AM, Twisk JWR, Visser CA, Rossum AC. Time course of functional recovery after revascularisation of hibernating myocardium: a contrast-enhanced CMR study. Eur Heart J. 2008; 29::20002005
    [Google Scholar]
  11. Byrne JG, Aklog L, Adams DH. Assesment and management of functional or ischemic mitral regurgitation. Lancet. 2000; 355:9217:17431744
    [Google Scholar]
  12. Fattouch K, Guccione F, Sampognaro R, Panzarella G, Corrado E, Navarra E, Calvaruso D, Ruvolo G. POINT: efficacy of adding mitral valve restrictive annuloplasty to coronary artery bypass grafting in patients with moderate ischemic mitral valve regurgitation: a randomized trial. J Thorac Cardiovasc Surg. 2009; 138:2:278285
    [Google Scholar]
  13. “Comparing the Effectiveness of a Mitral Valve Repair Procedure in Combination With Coronary Artery Bypass Grafting (CABG) Versus CABG Alone in People With Moderate Ischemic Mitral Regurgitation”. www.clinicaltrials.gov identification number: NCT00806988
http://instance.metastore.ingenta.com/content/journals/10.5339/gcsp.2013.16
Loading
  • Article Type: Research Article
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error